CoChat
Sign Up
Cited by 64

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Class III PI3K regulates organismal glucose homeostasis by providing negative feedback on hepatic insulin signalling

Nemazanyy, Ivan, Montagnac, Guillaume, Russell, Ryan C., Morzyglod, Lucille, Burnol, Anne-Françoise, Guan, Kun-Liang, Pende, Mario, Panasyuk, Ganna·2015·Nature Communications
DOI 10.1038/ncomms9283PMC PMC4579570
Open this paper in CoChat — free account

Abstract

Defective hepatic insulin receptor (IR) signalling is a pathogenic manifestation of metabolic disorders including obesity and diabetes. The endo/lysosomal trafficking system may coordinate insulin action and nutrient homeostasis by endocytosis of IR and the autophagic control of intracellular nutrient levels. Here we show that class III PI3K—a master regulator of endocytosis, endosomal sorting and autophagy—provides negative feedback on hepatic insulin signalling. The ultraviolet radiation resistance-associated gene protein (UVRAG)-associated class III PI3K complex interacts with IR and is stimulated by insulin treatment. Acute and chronic depletion of hepatic Vps15, the regulatory subunit of class III PI3K, increases insulin sensitivity and Akt signalling, an effect that requires functional IR. This is reflected by FoxO1-dependent transcriptional defects and blunted gluconeogenesis in Vps15 mutant cells. On depletion of Vps15, the metabolic syndrome in genetic and diet-induced models of insulin resistance and diabetes is alleviated. Thus, feedback regulation of IR trafficking and function by class III PI3K may be a therapeutic target in metabolic conditions of insulin resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms9283

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 62

  1. Pilch, P. F., Shia, M. A., Benson, R. J. & Fine, R. E. Coated vesicles participate in the receptor-mediated endocytosis of insulin. J. Cell Biol. 96, 133–138 (1983). · DOI
  2. Morcavallo, A. et al. Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform A. J. Biol. Chem. 287, 11422–11436 (2012). · DOI
  3. Fagerholm, S., Ortegren, U., Karlsson, M., Ruishalme, I. & Stralfors, P. Rapid insulin-dependent endocytosis of the insulin receptor by caveolae in primary adipocytes. PloS ONE 4, e5985 (2009). · DOI
  4. Valera Mora, M. E., Scarfone, A., Calvani, M., Greco, A. V. & Mingrone, G. Insulin clearance in obesity. J. Am. Coll. Nutr. 22, 487–493 (2003). · DOI
  5. Bevan, A. P. et al. Selective activation of the rat hepatic endosomal insulin receptor kinase. Role for the endosome in insulin signaling. J. Biol. Chem. 270, 10784–10791 (1995). · DOI
  6. Balbis, A., Baquiran, G., Bergeron, J. J. & Posner, B. I. Compartmentalization and insulin-induced translocations of insulin receptor substrates, phosphatidylinositol 3-kinase, and protein kinase B in rat liver. Endocrinology 141, 4041–4049 (2000). · DOI · Paper page
  7. Leavens, K. F. & Birnbaum, M. J. Insulin signaling to hepatic lipid metabolism in health and disease. Crit. Rev. Biochem. Mol. Biol. 46, 200–215 (2011). · DOI
  8. Mehrpour, M., Esclatine, A., Beau, I. & Codogno, P. Overview of macroautophagy regulation in mammalian cells. Cell Res. 20, 748–762 (2010). · DOI
  9. Kim, K. H. & Lee, M. S. Autophagy—a key player in cellular and body metabolism. Nat. Rev. Endocrinol. 10, 322–337 (2014). · DOI
  10. Trischitta, V. et al. Insulin internalization into monocytes is decreased in patients with type II diabetes mellitus. J. Clin. Endocrinol. Metab. 62, 522–528 (1986). · DOI
  11. Karakash, C. & Jeanrenaud, B. Insulin binding and removal by livers of genetically obese rats. Diabetes 32, 605–609 (1983). · DOI
  12. Backer, J. M. The regulation and function of Class III PI3Ks: novel roles for Vps34. Biochem. J. 410, 1–17 (2008). · DOI
  13. Panaretou, C., Domin, J., Cockcroft, S. & Waterfield, M. D. Characterization of p150, an adaptor protein for the human phosphatidylinositol (PtdIns) 3-kinase. Substrate presentation by phosphatidylinositol transfer protein to the p150.Ptdins 3-kinase complex. J. Biol. Chem. 272, 2477–2485 (1997). · DOI
  14. Kutateladze, T. G. Translation of the phosphoinositide code by PI effectors. Nat. Chem. Biol. 6, 507–513 (2010). · DOI
  15. Russell, R. C., Yuan, H. X. & Guan, K. L. Autophagy regulation by nutrient signaling. Cell Res. 24, 42–57 (2014). · DOI
  16. Kim, J. et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 152, 290–303 (2013). · DOI
  17. Russell, R. C. et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat. Cell Biol. 15, 741–750 (2013). · DOI · Paper page
  18. Byfield, M. P., Murray, J. T. & Backer, J. M. hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase. J. Biol. Chem. 280, 33076–33082 (2005). · DOI
  19. Thoresen, S. B., Pedersen, N. M., Liestol, K. & Stenmark, H. A phosphatidylinositol 3-kinase class III sub-complex containing VPS15, VPS34, Beclin 1, UVRAG and BIF-1 regulates cytokinesis and degradative endocytic traffic. Exp. Cell Res. 316, 3368–3378 (2010). · DOI
  20. Nemazanyy, I. et al. Defects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal disease. EMBO Mol. Med. 5, 870–890 (2013). · DOI · Paper page
  21. von Kleist, L. et al. Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell 146, 471–484 (2011). · DOI
  22. Lodhi, I. J. et al. Insulin stimulates phosphatidylinositol 3-phosphate production via the activation of Rab5. Mol. Biol. Cell 19, 2718–2728 (2008). · DOI
  23. Maffucci, T., Brancaccio, A., Piccolo, E., Stein, R. C. & Falasca, M. Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activation. EMBO J. 22, 4178–4189 (2003). · DOI
  24. Postic, C. et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274, 305–315 (1999). · DOI · Paper page
  25. Singh, R. et al. Autophagy regulates lipid metabolism. Nature 458, 1131–1135 (2009). · DOI · Paper page
  26. Matsumoto, M., Pocai, A., Rossetti, L., Depinho, R. A. & Accili, D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab. 6, 208–216 (2007). · DOI
  27. Samuel, V. T. et al. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes 55, 2042–2050 (2006). · DOI
  28. Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857–868 (1999). · DOI · Paper page
  29. Brunet, A. et al. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol. 156, 817–828 (2002). · DOI
  30. Matsuzaki, H., Daitoku, H., Hatta, M., Tanaka, K. & Fukamizu, A. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc. Natl Acad. Sci. USA 100, 11285–11290 (2003). · DOI
  31. Shah, O. J., Wang, Z. & Hunter, T. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr. Biol. 14, 1650–1656 (2004). · DOI
  32. Huang, J., Dibble, C. C., Matsuzaki, M. & Manning, B. D. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol. Cell. Biol. 28, 4104–4115 (2008). · DOI
  33. Yuan, H. X., Russell, R. C. & Guan, K. L. Regulation of PIK3C3/VPS34 complexes by MTOR in nutrient stress-induced autophagy. Autophagy 9, 1983–1995 (2013). · DOI
  34. Obenauer, J. C., Cantley, L. C. & Yaffe, M. B. Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 31, 3635–3641 (2003). · DOI
  35. Hornbeck, P. V., Chabra, I., Kornhauser, J. M., Skrzypek, E. & Zhang, B. PhosphoSite: a bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics 4, 1551–1561 (2004). · DOI
  36. Wei, Y. et al. EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance. Cell 154, 1269–1284 (2013). · DOI · Paper page
  37. Stein, M. P., Feng, Y., Cooper, K. L., Welford, A. M. & Wandinger-Ness, A. Human VPS34 and p150 are Rab7 interacting partners. Traffic 4, 754–771 (2003). · DOI
  38. Murray, J. T., Panaretou, C., Stenmark, H., Miaczynska, M. & Backer, J. M. Role of Rab5 in the recruitment of hVps34/p150 to the early endosome. Traffic 3, 416–427 (2002). · DOI · Paper page
  39. Christoforidis, S. et al. Phosphatidylinositol-3-OH kinases are Rab5 effectors. Nat. Cell Biol. 1, 249–252 (1999). · DOI · Paper page
  40. Hunker, C. M. et al. Role of Rab5 in insulin receptor-mediated endocytosis and signaling. Arch. Biochem. Biophys. 449, 130–142 (2006). · DOI
  41. Stein, M. P. et al. Interaction and functional analyses of human VPS34/p150 phosphatidylinositol 3-kinase complex with Rab7. Methods Enzymol. 403, 628–649 (2005). · DOI
  42. Ryu, J. et al. APPL1 potentiates insulin sensitivity by facilitating the binding of IRS1/2 to the insulin receptor. Cell Rep. 7, 1227–1238 (2014). · DOI
  43. Cheng, K. K. et al. APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice. Cell Metab. 9, 417–427 (2009). · DOI
  44. Mitsuuchi, Y. et al. Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2. Oncogene 18, 4891–4898 (1999). · DOI
  45. Schenck, A. et al. The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development. Cell 133, 486–497 (2008). · DOI
  46. Zoncu, R. et al. A phosphoinositide switch controls the maturation and signaling properties of APPL endosomes. Cell 136, 1110–1121 (2009). · DOI
  47. Dennis, P. A. & Aronson, N. N. Jr The effects of low temperature and chloroquine on 125I-insulin degradation by the perfused rat liver. Arch. Biochem. Biophys. 212, 170–176 (1981). · DOI
  48. Jarzyna, R., Kiersztan, A., Lisowa, O. & Bryla, J. The inhibition of gluconeogenesis by chloroquine contributes to its hypoglycaemic action. Eur. J. Pharmacol. 428, 381–388 (2001). · DOI
  49. Blazar, B. R. et al. In vivo chloroquine-induced inhibition of insulin degradation in a diabetic patient with severe insulin resistance. Diabetes 33, 1133–1137 (1984). · DOI
  50. Hostetler, K. Y., Reasor, M. & Yazaki, P. J. Chloroquine-induced phospholipid fatty liver. Measurement of drug and lipid concentrations in rat liver lysosomes. J. Biol. Chem. 260, 215–219 (1985). · DOI
  51. Horie, Y. et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J. Clin. Invest 113, 1774–1783 (2004). · DOI
  52. Ueno, T. et al. Loss of Pten, a tumor suppressor, causes the strong inhibition of autophagy without affecting LC3 lipidation. Autophagy 4, 692–700 (2008). · DOI
  53. Yecies, J. L. et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 14, 21–32 (2011). · DOI
  54. Menon, S. et al. Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. Sci. Signal 5, ra24 (2012). · DOI
  55. Banks, A. S. et al. Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in mice. Cell Metab. 14, 587–597 (2011). · DOI
  56. Zhang, K. et al. Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice. Endocrinology 153, 631–646 (2012). · DOI
  57. Kuma, A. et al. The role of autophagy during the early neonatal starvation period. Nature 432, 1032–1036 (2004). · DOI · Paper page
  58. Clark, J. B. & Clark, C. M. Jr Age-related changes in insulin receptor regulation in liver membranes from Zucker fatty rats. Endocrinology 111, 964–969 (1982). · DOI
  59. Tannour-Louet, M., Porteu, A., Vaulont, S., Kahn, A. & Vasseur-Cognet, M. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver. Hepatology 35, 1072–1081 (2002). · DOI
  60. Panasyuk, G. et al. PPARgamma contributes to PKM2 and HK2 expression in fatty liver. Nat. Commun. 3, 672 (2012). · DOI
  61. Zhang, H. et al. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J. Clin. Invest. 112, 1223–1233 (2003). · DOI
  62. de Araujo, M. E., Huber, L. A. & Stasyk, T. Isolation of endocitic organelles by density gradient centrifugation. Methods Mol. Biol. 424, 317–331 (2008). · DOI

Cited by

Sorted by citations

Metadata

Authors
Nemazanyy, I., Montagnac, G., Russell, R. C., Morzyglod, L., Burnol, A.-F., Guan, K.-L., Pende, M., & Panasyuk, G.
Venue
Nature Communications
Publisher
Springer Science and Business Media LLC
Published
2015-09-21
Volume
6
Issue
1
ISSN
2041-1723
DOI
10.1038/ncomms9283
PMC
PMC4579570
Cited by
64
References
8
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review